Returns on PME have been quite acceptable (especially considering the current SP). Management seem to be very good. Seems very limited downside, and massive upside for the following main reasons:
1. There is a $30 billion fund in the US to get health industry companies to go with electronic records.
2. There is some consolidation going on to attempt to take advantage of this (or maybe it is going on to make investment bankers lots of money).
3. PME has a high ROE and ROA, low gearing, low costs, lots of experience.
Yippee yi yo
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$317.00 |
Change
-0.340(0.11%) |
Mkt cap ! $33.11B | |||
| Open | High | Low | Value | Volume |
| $319.34 | $321.99 | $314.91 | $31.58M | 99.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 142 | $316.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $317.94 | 142 | 2 |
View Market Depth
| Last trade - 16.10pm 14/07/2025 (20 minute delay) ? |
| PME (ASX) Chart |